Activity of Cefiderocol and Comparators against Isolates from Cancer Patients.
Acinetobacter
/ drug effects
Amikacin
/ pharmacology
Anti-Bacterial Agents
/ pharmacology
Azabicyclo Compounds
/ pharmacology
Carbapenem-Resistant Enterobacteriaceae
/ drug effects
Ceftazidime
/ pharmacology
Cephalosporins
/ pharmacology
Drug Combinations
Gram-Negative Bacteria
/ drug effects
Humans
Meropenem
/ pharmacology
Microbial Sensitivity Tests
Neoplasms
/ pathology
Pseudomonas aeruginosa
/ drug effects
Stenotrophomonas maltophilia
/ drug effects
Cefiderocol
Gram-negative isolates
Pseudomonas aeruginosa
Stenotrophomonas maltophilia
cefiderocol
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
21 04 2020
21 04 2020
Historique:
received:
26
09
2019
accepted:
12
02
2020
pubmed:
20
2
2020
medline:
23
3
2021
entrez:
20
2
2020
Statut:
epublish
Résumé
Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at ≤4 mg/liter. It had potent activity against extended-spectrum β-lactamase-positive
Identifiants
pubmed: 32071053
pii: AAC.01955-19
doi: 10.1128/AAC.01955-19
pmc: PMC7179642
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Azabicyclo Compounds
0
Cephalosporins
0
Drug Combinations
0
avibactam, ceftazidime drug combination
0
Amikacin
84319SGC3C
Ceftazidime
9M416Z9QNR
Meropenem
FV9J3JU8B1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 Rolston et al.
Références
J Antimicrob Chemother. 2016 Mar;71(3):670-7
pubmed: 26645269
Front Microbiol. 2013 Mar 14;4:48
pubmed: 23504089
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4384-6
pubmed: 27139465
Clin Infect Dis. 2011 Feb 15;52(4):e56-93
pubmed: 21258094
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31085510
Support Care Cancer. 2016 Jul;24(7):2819-26
pubmed: 27098065
Antimicrob Agents Chemother. 2015 Nov 16;60(2):729-34
pubmed: 26574013
Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):841-50
pubmed: 23354675